Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07212673 · ClinicalTrials.gov registry record · NA
Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder
A NA study of Binge-Eating Disorder, sponsored by Yeshiva University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07212673: Recruiting NA study of Binge-Eating Disorder, sponsored by Yeshiva University.
NCT07212673 is a NA study of Binge-Eating Disorder that is actively recruiting participants, run by Yeshiva University. The registered enrollment target is 40 participants, below the 1,142-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07212673, a NA study of Binge-Eating Disorder, is actively recruiting participants, sponsored by Yeshiva University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will evaluate the acceptability and feasibility of a 16-session digital mindfulness-based and cognitive behavioral therapy (CBT) intervention for binge eating disorder (BED) + coached self-monitoring vs. a coached self-monitoring intervention. This study is a pilot randomized controlled trial.
Primary Outcome
Number of participants completing intervention
Conditions Studied
Interventions
- BEHAVIORAL CBT-based Mindful Courage
- BEHAVIORAL Coached Self-Monitoring
Study Locations (1)
New York
- Yeshiva University - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-11-02 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT07212673 shows while recruiting
NCT07212673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,142-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 2 interventions - of which CBT-based Mindful Courage is the first listed.
NCT07212673 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07212673 about?
NCT07212673 is a clinical study titled "Combining Digital Cognitive-behavior Therapy With Mindfulness Training for Binge Eating Disorder". The investigators will evaluate the acceptability and feasibility of a 16-session digital mindfulness-based and cognitive behavioral therapy (CBT) intervention for binge eating disorder (BED) + coached self-monitoring vs. a coached self-monitoring intervention. This study is a pilot randomized contr...
What is the current status of trial NCT07212673?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-11-02. Estimated completion is 2027-10-01.
What conditions does trial NCT07212673 study?
This clinical trial studies the following conditions: Binge-Eating Disorder.
What interventions are being tested in trial NCT07212673?
The interventions under investigation include: CBT-based Mindful Courage (BEHAVIORAL), Coached Self-Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT07212673?
This trial is sponsored by Yeshiva University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07212673 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07212673's enrollment target sits among peer trials
40 27th of 37 higher than 9 of 37 other Binge-Eating Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI